白血球去除疗法市场规模、份额、成长分析，按类型、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

2022年全球白血球分离疗法市场规模为6,630万美元，从2023年的7,187万美元成长到2031年的1,3702万美元，复合年增长率预计为8.40%。

由于血液疾病和自体免疫疾病的增加，全球白血球去除术市场正在显着成长。这种选择性分离白血球的过程在白血病和自体免疫疾病等疾病的治疗中发挥重要作用，同时也推进了诊断方法。白血球分离系统的创新提高了此手术的有效性和安全性，增加了其作为可靠治疗选择的吸引力。然而，与所需设备和训练有素的人员相关的意识有限和高成本可能会阻碍市场成长。有大量的治疗机会，特别是在白血球去除术、个人化医疗和基于细胞的疗法（如 CAR-T 细胞疗法）的交叉领域。随着医疗保健基础设施的发展，对具有成本效益的解决方案的研究和投资有可能进一步扩大这一重要的市场领域。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

白血球去除术市场规模：依类型

• 市场概况
• 一次性的
• 装置
  • 离心分离机
  • 膜分离设备

白血球去除术市场规模：依应用分类

• 市场概况
• 研究用途
• 治疗用途

白血球去除术市场规模：依最终用户划分

• 市场概况
• 血液成分供应商和血液中心
• 学术研究所
• 製药和生物技术公司
• 医院及输血中心

白血球去除术市场规模：依地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Terumo BCT
• Fresenius SE & Co. KGaA
• Haemonetics Corporation
• Asahi Kasei Corporation
• Macopharma SA
• Miltenyi Biotec
• Medica Spa
• Puriblood Medical Co. Ltd.
• Beijing ZKSK Technology Co. Ltd.
• SB-Kawasumi Laboratories, Inc.
• Nikkiso Co., Ltd.
• Charles River Laboratories International, Inc.
• Discovery Life Sciences, Inc.
• Precision for Medicine, Inc.
• StemExpress, LLC
• Lonza Group AG
• Caltag Medsystems Limited
• Stemcell Technologies
• Trina Bioreactives AG
• AcceGen
• First Choice Bio LLC

结论和建议

Global Leukapheresis Market size was valued at USD 66.3 million in 2022 and is poised to grow from USD 71.87 million in 2023 to USD 137.02 million by 2031, growing at a CAGR of 8.40% during the forecast period (2024-2031).

The global leukapheresis market is experiencing significant growth, driven by rising incidences of hematologic disorders and autoimmune diseases. This process of selectively separating white blood cells plays a crucial role in treating conditions like leukemia and autoimmune disorders while advancing diagnostic methods. Technological innovations in leukapheresis systems have improved procedure efficacy and safety, enhancing their appeal as a reliable therapeutic option. However, market growth could be hindered by limited awareness and high costs associated with the necessary equipment and trained personnel. Opportunities abound, especially in the intersection of leukapheresis and personalized medicine, as well as cell-based therapies like CAR T-cell treatment. As healthcare infrastructure develops, investment in research and cost-effective solutions could further expand this vital market sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Leukapheresis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Leukapheresis Market Segmental Analysis

Global Leukapheresis Market is segmented by Type, Application, End User, and region. Based on Type, the market is segmented into Disposables, Devices. Based on Application, the market is segmented into Research Applications, Therapeutic Applications. Based on End User, the market is segmented into Blood component providers & blood centers, Academic & research institutes, Pharmaceutical & biotechnology companies, Hospitals & transfusion centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Leukapheresis Market

The global leukapheresis market is primarily driven by the growing prevalence of hematologic disorders, including leukemia and lymphoma. As the incidence of these conditions continues to rise, the demand for effective treatment options becomes increasingly critical. Leukapheresis is instrumental in managing elevated white blood cell counts associated with these disorders, as it facilitates the rapid removal of leukemic cells from the bloodstream. This procedure not only alleviates symptoms but also helps in preparing patients for further therapeutic interventions. Consequently, the increasing recognition of leukapheresis as a vital treatment option significantly fuels market growth in this sector.

Restraints in the Global Leukapheresis Market

The global leukapheresis market faces several challenges that may impede its growth. A significant factor is the limited awareness of both healthcare providers and patients regarding the advantages of leukapheresis procedures. This lack of knowledge highlights the need for comprehensive educational initiatives aimed at fostering a better understanding of this therapeutic option. Additionally, the high expenses associated with leukapheresis devices and consumables pose another barrier, especially in resource-limited environments. Moreover, the requirement for skilled healthcare professionals to conduct these procedures further complicates accessibility, underscoring the necessity for targeted strategies to improve awareness and affordability in the market.

Market Trends of the Global Leukapheresis Market

The global leukapheresis market is witnessing a significant trend towards integration with cell-based therapies, particularly chimeric antigen receptor (CAR) T-cell therapy. This approach allows for the efficient collection and genetic modification of patient-derived white blood cells, which are essential for developing effective treatments against cancer. As healthcare providers increasingly recognize the potential of combining leukapheresis with advanced cell therapies, demand for leukapheresis technologies is expected to surge. This synergy not only enhances treatment efficacy but also drives innovation in leukapheresis procedures, positioning it as a cornerstone in the evolving landscape of personalized cancer care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Leukapheresis Market Size by Type & CAGR (2024-2031)

• Market Overview
• Disposables
• Devices
  • Centrifugal Devices
  • Membrane Separators

Global Leukapheresis Market Size by Application & CAGR (2024-2031)

• Market Overview
• Research Applications
• Therapeutic Applications

Global Leukapheresis Market Size by End User & CAGR (2024-2031)

• Market Overview
• Blood component providers & blood centers
• Academic & research institutes
• Pharmaceutical & biotechnology companies
• Hospitals & transfusion centers

Global Leukapheresis Market Size & CAGR (2024-2031)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Terumo BCT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius SE & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Haemonetics Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asahi Kasei Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macopharma SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medica Spa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Puriblood Medical Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing ZKSK Technology Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SB-Kawasumi Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nikkiso Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Discovery Life Sciences, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision for Medicine, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• StemExpress, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caltag Medsystems Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stemcell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trina Bioreactives AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• First Choice Bio LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation